CAS: 152923-56-3
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
Daclizumab REF: TM-T73689CAS: 152923-56-3 | SDS-PAGE:95% SEC-HPLC:99.99% | 198.00 €~2,211.00 € | Wed 16 Oct 24 | |
Daclizumab REF: 3D-CLA1061CAS: 152923-56-3 | - - - | To inquire | Mon 28 Oct 24 |
Daclizumab
CAS:152923-56-3
Daclizumab (Zenapax), a humanized antibody, blocks IL-2 by targeting CD25, used in multiple sclerosis.
Purity:
SDS-PAGE:95% SEC-HPLC:99.99%
Color and Shape:
Solid
Ref: TM-T73689
1mg | 198.00 € | ||
5mg | 503.00 € | ||
10mg | 804.00 € | ||
25mg | 1,198.00 € | ||
50mg | 1,644.00 € | ||
100mg | 2,211.00 € |
Estimated delivery in United States, on Wednesday 16 Oct 2024
Ref: 3D-CLA1061
Undefined size | To inquire |
Estimated delivery in United States, on Monday 28 Oct 2024